Others

Sperm motility agonist-1 (compound 745) is a Sperm motility agonist.

NVOC cage-TMP-Halo is a cell-permeable and photoactivatable protein dimerization inducer.

rTRD01 is a TDP-43 ligand that binds to TDP-43’s RRM1 and RRM2 domains (Kd=89 uM for TDP-43102–269).

H2-Gamendazole is a derivative of Lonidamine that reduces cyst formation in polycystic kidney disease and is used in autosomal dominant polycystic kidney disease research.

CRT0063465 is a Ligand of HumanPGK1andStress Sensor DJ1, with theKdof 24 μM ofPGK1.

AEP-IN-2 is an asparagine endopeptidase (AEP) inhibitor via block AEP cleavage of APP and Tau.

Biotin-PEG3-CONH-Ph-CF3-diazirine is a biotin labeled PEG3 derivative.

AC-099 hydrochloride (compound 3) is a selective NPFF2R full agonist (EC50=1189 nM) and NPFF1R partial agonist (EC50=2370 nM).

PAT1inh-B01 is a selective SLC26A6 inhibitor.

GPR52 receptor modulator 1 (Procedure 1) is a GPR52 receptor modulator with the potential to study neuropsychiatric diseases.

MARK4 inhibitor 4 is a MARK4 inhibitor with an IC50 of 1.49 μM.

2,4-Difluorophenylethynylcobalamin is a potential B12 antivitamin via binding to human B12 -processing enzyme CblC with high affinity (KD=130 nm).

JM6 is a weak kynurenine 3-monooxygenase (KMO) inhibitor with an IC50 of 19.85 μM for mouse KMO.

P2X7 receptor antagonist-4 (Compound 14a) is a P2X7R antagonist.

GPR3 agonist-2(compound 32) is a potent full agonist of G protein-coupled receptor 3, with the IC50of 260 nM.

GPR34 receptor antagonist 3 (Compound 5e) is a class of GRP34 antagonists, IC50 is 0.680 μM.

O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.

Cisd2 agonist 1 (Compound 4q) is a Cisd2 agonist (EC50: 34 nM).

Cisd2 agonist 2 (compound 6) is an orally active Cisd2 activator (EC50=191 nM), while the Cisd2 levels is correlated with nonalcoholic fatty liver disease (NAFLD).

Tyramide alkyne is an alternative labeling substrate that can be coupled to detection or enrichment moieties via a Copper-catalyzed Azide/Alkyne Cycloaddition (CuAAC) “click” reaction.

hPL-IN-2 (compound 2u) is a potent, reversible, and non-competitive inhibitor of pancreatic lipase (IC50: 1.63 μM) and can be used in anti-obesity research.

AJ2-71 is a SLCl5A4 inhibitor.

AJ2-30 is a SLCl5A4 inhibitor.

5-Azacytidine 5’-triphosphate sodium is a cytidine analog.